AW
Angela Weyand
Physician · University of Michigan Health-Ann Arbor
Credentials: · · · · ·
History
2013–2014- 2010–2013
Pediatrics
Research
A biomarker panel for acute graft-versus-host disease
Blood · 2009 · 327 citations
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Blood Advances · 2021 · 307 citations
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
New England Journal of Medicine · 2023 · 177 citations
- EQ
9 papers
9 papers
8 papers
8 papers
7 papers
6 papers
- NC
6 papers
6 papers
Clinical trials
- 2019–2026
ATHN 9: Severe VWD Natural History Study
Principal investigator · Completed
American Thrombosis and Hemostasis Network
- 2022–2028
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Site PI · Recruiting · Phase 1
Bleeding and Clotting Disorders Institute Peoria, Illinois